Zobrazeno 1 - 10
of 15
pro vyhledávání: '"M. Asunción Iborra"'
Autor:
Bartolomé Carrilero, María Romay-Barja, M. Asunción Iborra, Luis J. Gil-Gallardo, Marina Simón, Cristina Vázquez, Manuel Segovia
Publikováno v:
Pediatric Infectious Disease Journal. 39:494-499
BACKGROUND Chagas disease has become a global health problem, with the pediatric population being especially vulnerable. Our aim was to describe the clinical-epidemiologic aspects of disease in this population, as well as tolerance and adherence to t
Publikováno v:
Enfermedades infecciosas y microbiologia clinica (English ed.). 38:300-301
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 38:300-301
Autor:
Bartolomé Carrilero, Marina Simón, María Romay-Barja, M. Carmen Thomas, M. Asunción Iborra, Laura Murcia, Agustín Benito, Manuel Carlos López, Manuel Segovia, Luis J. Gil-Gallardo
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Objectives Congenital Chagas Disease (CCD) has become a global health problem. Early diagnosis and treatment is essential for the cure of the disease. Our aim was to evaluate techniques and samples used for the diagnosis of CCD in order to improve di
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 31:26-34
Trypanosoma cruzi infection, or Chagas disease, was discovered more than 100 years ago by Carlos Chagas. Although the infection kills more than 15,000 people each year, it is still classified as a neglected tropical disease. Today, this disease affec
Autor:
Manuel Segovia-Hernández, Míriam Albert-Hernández, Carmen Márquez-Contreras, M. Asunción Iborra-Bendicho
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 30:463-465
Resumen Objetivo Evaluar un nuevo inmunoensayo quimioluminiscente de microparticulas (ARCHITECT Chagas®, Abbott). Metodos Estudio aleatorio con 165 muestras mediante 2 tecnicas serologicas diferentes. El ensayo ARCHITECT Chagas® se realizo empleand
Publikováno v:
Enfermedades infecciosas y microbiologia clinica. 31
Trypanosoma cruzi infection, or Chagas disease, was discovered more than 100 years ago by Carlos Chagas. Although the infection kills more than 15,000 people each year, it is still classified as a neglected tropical disease. Today, this disease affec
Autor:
M Asunción, Iborra-Bendicho, Miriam, Albert-Hernández, Carmen, Márquez-Contreras, Manuel, Segovia-Hernández
Publikováno v:
Enfermedades infecciosas y microbiologia clinica. 30(8)
To evaluate a new chemiluminescent microparticle immunoassay (ARCHITECT Chagas(®), Abbott).In this study, 165 samples were tested by two different serological tests. The ARCHITECT Chagas(®) assay was performed using ARCHITECT i2000(SR) system (Abbo
Publikováno v:
Enfermedades infecciosas y microbiologia clinica. 29(10)
Publikováno v:
The Journal of antimicrobial chemotherapy. 65(8)
This prospective study focused on the evaluation of antiparasitic therapy in chronic Chagas' disease, monitored by PCR.One hundred and eighty-one patients, all seropositive for Trypanosoma cruzi infection, underwent specific chemotherapy with benznid